| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLAC | Common Stock | Other | $0 | -20K | -1.16% | $0.00 | 1.71M | Feb 14, 2023 | Direct | F1, F2 |
| transaction | BLAC | Common Stock | Other | $0 | -20K | -1.17% | $0.00 | 1.69M | Feb 14, 2023 | Direct | F1, F3 |
| transaction | BLAC | Common Stock | Other | $0 | -20K | -1.19% | $0.00 | 1.67M | Feb 14, 2023 | Direct | F1, F4 |
| transaction | BLAC | Common Stock | Other | $0 | -20K | -1.2% | $0.00 | 1.65M | Feb 14, 2023 | Direct | F1, F5 |
| transaction | BLAC | Common Stock | Other | $0 | -20K | -1.22% | $0.00 | 1.63M | Feb 14, 2023 | Direct | F1, F6 |
| transaction | BLAC | Common Stock | Other | $0 | -225K | -13.85% | $0.00 | 1.4M | Feb 14, 2023 | Direct | F1, F7 |
| transaction | BLAC | Common Stock | Other | $0 | -30K | -2.14% | $0.00 | 1.37M | Feb 14, 2023 | Direct | F1, F8 |
| transaction | BLAC | Common Stock | Award | $4.3M | +430K | +31.39% | $10.00 | 1.8M | Feb 14, 2023 | Direct | F1, F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BLAC | Private Placement Warrants | Purchase | $4.3M | +430K | $10.00 | 430K | Feb 14, 2023 | Common Stock | 430K | $11.50 | Direct | F10 | |
| transaction | BLAC | Warrant for Common Stock | Other | $0 | -20K | -4.65% | $0.00 | 410K | Feb 14, 2023 | Common Stock | 20K | $11.50 | Direct | F11 |
| transaction | BLAC | Warrant for Common Stock | Other | $0 | -20K | -4.88% | $0.00 | 390K | Feb 14, 2023 | Common Stock | 20K | $11.50 | Direct | F12 |
| Id | Content |
|---|---|
| F1 | Represents shares of common stock held by Bellevue Global Life Sciences Investors LLC, the sponsor of the Issuer (the "Sponsor") whose general partner is Bellevue Capital Management LLC ("Bellevue Capital"). Kuk Hyoun Hwang is the managing partner of Bellevue Capital and has voting and dispositive power over the shares held by the Sponsor. |
| F2 | Represents the shares transferred by the Sponsor to Mr. Jin Whan Park for his board service. |
| F3 | Represents the shares transferred by the Sponsor to Mr. Steven Reed for his board service. |
| F4 | Represents the shares transferred by the Sponsor to Mr. In Chul Chung for his board service. |
| F5 | Represents the shares transferred by the Sponsor to Mr. Husun Euh for his board service. |
| F6 | Represents the shares transferred by the Sponsor to Mr. Rad Roberts for his board service. |
| F7 | Represents the shares that were forfeited as a result of the underwriters' not exercising their over-allotment option. |
| F8 | Represents the shares transferred by the Sponsor to the underwriters. |
| F9 | The Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement that occurred simultaneously with the consummation of the Issuer's Public Offering. Each Private Placement Unit consists of one share of Common Stock, one redeemable warrant entitling the holder to purchase one share of Common Stock, and one right which entitles the holder thereof to receive one-tenth (1/10) of a share of common stock. |
| F10 | The Sponsor purchased an aggregate of 430,000 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement that occurred simultaneously with the consummation of the Issuer's Public Offering. Each Private Placement Unit consists of one share of Common Stock, one redeemable warrant entitling the holder to purchase one share of Common Stock, and one right which entitles the holder thereof to receive one-tenth (1/10) of a share of common stock. The Private Placement Warrants are exercisable only to purchase whole shares of Common Stock at an exercise price of $11.50 per share, subject to adjustments. Each warrant will become exercisable 30 days after the Issuer's Public Offering. Each warrant will expire five years after the completion of the Issuer's Public Offering, or earlier upon redemption or liquidation. |
| F11 | Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Dr. In Chul Chung for his service as Chairman of the Audit Committee. |
| F12 | Represents the warrant to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. Steven Reed for his service as Chairman of the Board of Directors. |